Biologic therapeutics as the fourth modality in cancer treatment.
Masucci
G
G
Department of Oncology, Karolinska Hospital, Stockholm, Sweden.
Mellstedt
H
H
D001685:Biological Factors / Q000627:therapeutic use; D016207:Cytokines; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*
D001685:Biological Factors; D016207:Cytokines; D007376:Interleukin-2